Topics include, but are not limited to:
- Coordinating new drug application (NDA)and patent portfolio strategy
- Preclinical R&D and patent considerations
- Clinical trials and regulatory considerations
- Trademark (TM) and nonproprietary name considerations
- Acquiring and In-Licensing Pharmaceutical Products:
- Pre-litigation Investigations and Due Diligence
- Market Entry Business Considerations for Generic Companies